NPPA allows price hike for coronary stents to reflect inflation, impacting heart patients' treatment costs in India.
NPPA allows stent manufacturers to revise prices by 1.74% based on WPI, ensuring compliance with DPCO regulations.
NPPA notifies revised prices of certain products based on WPI increase: Gireesh Babu, New Delhi Saturday, March 29, 2025, 08:00 Hrs [IST] The National Pharmaceutical Pricing Autho ...
NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果